Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Produced naturally by lactic acid bacteria, L-lactic acid is found in many fermented milk products such as yogurt, and also in pickled vegetables, cured meats and fish. It also serves as a quality parameter in wine, beer, whole egg, whole egg powder, and juices.

Objective: To validate the performance of the Enzytec™ Liquid D-/L-Lactic acid for the determination of the sum of D- and L-lactic acid in food and beverages such as milk and (fermented) milk products, fermented vegetable products, wines, beer, fruit and vegetable juices, egg and egg powder.

Methods: The kit contains two ready-to-use components which makes handling easy and suitable for automation. Both lactic acids react in the presence of NAD and D- or L-Lactate dehydrogenase to pyruvate and NADH. The NADH formed is equivalent to the amount of D-/L-lactic acid converted.

Results: Ascorbic acid, 3-hydroxybutyric acid, and sulfite were found to have a low activity at concentrations higher than 0.5, 0.05, and 0.1 g/L, respectively. Oxaloacetic acid and D-fructose do not interfere at concentrations at or below 0.2 and 20 g/L, respectively. The calculated LOD when using a test solution volume of 100 µL is 3 mg/L and the LOQ is 10 mg/L. The practical upper measurement range is 600 mg/L. Relative intermediate precision was between 3.8 and 5.3% for pineapple juice, sauerkraut juice, wine and liquid egg. Cream cheese Certified Reference Materials showed a recovery between 98 and 103%. A reference wine was found with a recovery of 104%. For automation, three applications with different test solution volumes were validated. Linearity is given from 4 up to 3125 mg/L.

Conclusions: The method is robust and accurate and was approved as AOAC Official Method of Analysis℠.

Highlights: The ready-to-use components of the test kit have a shelf life of at least 24 months.

Download full-text PDF

Source
http://dx.doi.org/10.1093/jaoacint/qsaf046DOI Listing

Publication Analysis

Top Keywords

d-/l-lactic acid
12
l-lactic acid
12
acid
10
enzytec™ liquid
8
liquid d-/l-lactic
8
official method
8
fermented milk
8
milk products
8
egg egg
8
ready-to-use components
8

Similar Publications

Wound healing is a complex process that may result in healthy tissue regeneration, but problematic chronic wounds exhibit fibrosis and persistent inflammation. To improve wound outcomes, the application of pro-proliferative polymers as bioresorbable particles was investigated for the first time. The surface of bioresorbable poly(D,L-lactic acid) (PLA) microparticles is decorated with a pro- and anti-proliferative polymer that adheres to the surface for a minimum of 21 days.

View Article and Find Full Text PDF

Objective: This study aimed to develop and characterize biodegradable nanofibrous scaffolds composed of poly(L-co-D,L-lactic acid) (PLDLA), nano-hydroxyapatite (nHA) synthesized from recycled mussel shells, and nanoemulsified chlorhexidine (nCHX) for guided periodontal regeneration (GPR).

Methods: nHA was synthesized from Perna perna mussel shells via wet chemical precipitation and characterized by SEM, FTIR, XRD, Raman, TGA, and zeta potential. Electrospun PLDLA/polycaprolactone (PCL) scaffolds were functionalized with nHA and/or nCHX.

View Article and Find Full Text PDF

Combination Therapy With Poly D-L Lactic Acid and Autologous Fat Transplantation for Infraorbital Rejuvenation.

J Craniofac Surg

August 2025

Division in Anatomy and Developmental Biology, Department of Oral Biology, Human Identification Research Institute, BK21 FOUR Project, Yonsei University College of Dentistry, Seoul, South Korea.

Background: Multiple approaches exist for treating infraorbital hollowing, including hyaluronic acid fillers and autologous fat transfer. However, traditional single-modality treatments often present limitations such as the Tyndall effect or unpredictable fat retention rates.

Objective: To evaluate the efficacy and safety of a novel combination therapy using poly-D,L-lactic acid (PDLLA) with autologous fat transplantation for infraorbital rejuvenation.

View Article and Find Full Text PDF

Intranasal delivery of rapamycin via brain-targeting polymeric micelles for Alzheimer's disease treatment.

Int J Pharm

October 2025

Industrial Pharmacy, Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, United States. Electronic address:

Alzheimer's disease (AD) is a long-term neurological disorder associated with neuroinflammation and amyloid-beta (Aβ) aggregation, which leads to a decline in cognitive and behavioral changes. Rapamycin (Rapa) is an immunosuppressive drug effective in preventing organ rejection after a kidney transplant. In the last few years, orally delivered Rapa has emerged as a potential candidate for improving cognitive function in patients with AD.

View Article and Find Full Text PDF

Invited Discussion on: The AestheBody Guide-A Practical Approach to AestheFill Injection Beyond the Face.

Aesthetic Plast Surg

August 2025

Li-An Medical Clinic, 4F., No. 267, Lequn 2nd Rd., Zhongshan Dist., Taipei City, 104452, Taiwan.

Level of Evidence V This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.

View Article and Find Full Text PDF